Sort   by:  
 Page size 
UnknownAssociation of Alzheimer's and Lewy body disease pathology with basal forebrain volume and cognitive impairment.
Not available
S-EPMC11771035 | biostudies-literature
UnknownValidation of a Quantitative Proton Nuclear Magnetic Resonance Spectroscopic Screening Method for Coffee Quality and Authenticity (NMR Coffee Screener).
Not available
S-EPMC7023380 | biostudies-literature
UnknownReduced expression of fMRI subsequent memory effects with increasing severity across the Alzheimer’s disease risk spectrum
Not available
S-EPMC12290606 | biostudies-literature
UnknownAlpha-synuclein quantitative seed amplification assay predicts conversion to dementia.
Not available
S-EPMC12828062 | biostudies-literature
UnknownFDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations.
Not available
S-EPMC6355852 | biostudies-literature
UnknownComparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent.
Not available
S-EPMC12858606 | biostudies-literature
UnknownSerum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.
Not available
S-EPMC9835320 | biostudies-literature
UnknownBrain atrophy staging in spinocerebellar ataxia type 3 for clinical prognosis and trial enrichment.
Not available
S-EPMC12800623 | biostudies-literature
UnknownHarmonizing neuropsychological assessment for mild neurocognitive disorders in Europe.
Not available
S-EPMC9642857 | biostudies-literature
UnknownMiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints.
Not available
S-EPMC7840941 | biostudies-literature
Sort   by:  
 Page size